FR2520233B1 - - Google Patents

Info

Publication number
FR2520233B1
FR2520233B1 FR8201327A FR8201327A FR2520233B1 FR 2520233 B1 FR2520233 B1 FR 2520233B1 FR 8201327 A FR8201327 A FR 8201327A FR 8201327 A FR8201327 A FR 8201327A FR 2520233 B1 FR2520233 B1 FR 2520233B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8201327A
Other languages
French (fr)
Other versions
FR2520233A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR8201327A priority Critical patent/FR2520233A1/fr
Priority to US06/459,647 priority patent/US4504494A/en
Priority to BE0/209979A priority patent/BE895718A/fr
Priority to CA000420357A priority patent/CA1187800A/fr
Priority to DE19833302739 priority patent/DE3302739A1/de
Priority to GB08302283A priority patent/GB2113547B/en
Priority to JP58010664A priority patent/JPS58134025A/ja
Priority to CH456/83A priority patent/CH653554A5/fr
Priority to IT19306/83A priority patent/IT1193627B/it
Priority to AU10914/83A priority patent/AU1091483A/en
Publication of FR2520233A1 publication Critical patent/FR2520233A1/fr
Application granted granted Critical
Publication of FR2520233B1 publication Critical patent/FR2520233B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8201327A 1982-01-28 1982-01-28 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau Granted FR2520233A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8201327A FR2520233A1 (fr) 1982-01-28 1982-01-28 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
US06/459,647 US4504494A (en) 1982-01-28 1983-01-20 Preparation of anthralin solutions or suspensions in aromatic esters and their use for diseases of the skin and nails
CA000420357A CA1187800A (fr) 1982-01-28 1983-01-27 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau et des ongles
DE19833302739 DE3302739A1 (de) 1982-01-28 1983-01-27 Oxidationsstabiles mittel
BE0/209979A BE895718A (fr) 1982-01-28 1983-01-27 Composition d'anthralines dans un ester aromatique et utilisation dans le traitement des maladies de la peau et des ongles
GB08302283A GB2113547B (en) 1982-01-28 1983-01-27 Compositions containing anthralin
JP58010664A JPS58134025A (ja) 1982-01-28 1983-01-27 芳香族エステルに溶解又は分散させたアントラリン又はその誘導体のうちの一つを含有する組成物
CH456/83A CH653554A5 (fr) 1982-01-28 1983-01-27 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique utilisable dans le traitement des maladies de la peau et des ongles.
IT19306/83A IT1193627B (it) 1982-01-28 1983-01-27 Composizione di antralina oppure di uno dei suoi derivati in un estere aromatico e suo impiego nel trattamento di matlattie della pelle e delle unghie
AU10914/83A AU1091483A (en) 1982-01-28 1983-01-28 Anthralin or ester derivatives for skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8201327A FR2520233A1 (fr) 1982-01-28 1982-01-28 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau

Publications (2)

Publication Number Publication Date
FR2520233A1 FR2520233A1 (fr) 1983-07-29
FR2520233B1 true FR2520233B1 (enExample) 1985-05-17

Family

ID=9270406

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8201327A Granted FR2520233A1 (fr) 1982-01-28 1982-01-28 Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau

Country Status (10)

Country Link
US (1) US4504494A (enExample)
JP (1) JPS58134025A (enExample)
AU (1) AU1091483A (enExample)
BE (1) BE895718A (enExample)
CA (1) CA1187800A (enExample)
CH (1) CH653554A5 (enExample)
DE (1) DE3302739A1 (enExample)
FR (1) FR2520233A1 (enExample)
GB (1) GB2113547B (enExample)
IT (1) IT1193627B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141626B (en) * 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
NZ208338A (en) * 1983-06-09 1987-11-27 Bristol Myers Co Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant
FR2569561B1 (fr) * 1984-08-30 1990-05-18 Oreal Composition stable d'anthraline dans des triglycerides d'acides gras satures d'origine vegetale ayant de 6 a 12 atomes de carbone
US5340579A (en) * 1984-11-20 1994-08-23 Farmaka S.R.L. Method of treating dermatological conditions
DE3603859A1 (de) * 1986-02-07 1987-08-13 Roehm Pharma Gmbh Abwaschbare topische zubereitung zur therapie der psoriasis
US5178881A (en) * 1991-04-12 1993-01-12 Leonard Mackles Anhydrous topical compositions which dry rapidly on contact
US5476664A (en) * 1994-04-15 1995-12-19 Leonard Bloom Treatment of warts using anthralins and occlusion
US6214915B1 (en) * 1998-12-10 2001-04-10 General Electric Company Stabilized thermoplastic compositions
AU8531101A (en) * 2000-08-29 2002-03-13 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
US20050152858A1 (en) * 2003-07-11 2005-07-14 Isp Investments Inc. Solubilizing agents for active or functional organic compounds
US20060067900A1 (en) * 2004-09-29 2006-03-30 Isp Investments Inc. Method and composition for imparting high shine to a polymeric substrate
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281225A (enExample) * 1961-07-20
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
GB1504007A (en) * 1976-06-28 1978-03-15 Dermal Lab Ltd Compositions containing dithranol
GB1574090A (en) * 1977-07-06 1980-09-03 Drythanol Ltd Dithranol composition for the treatment of psoriasis
US4326224A (en) * 1977-08-15 1982-04-20 Matsushita Electric Industrial Co. Ltd. Automatic signal compensation recording and reproducing apparatus
DD139793A1 (de) * 1978-11-06 1980-01-23 Waltraud Braun Mittel gegen psoriasis
US4293544A (en) * 1979-03-07 1981-10-06 Finetex Incorporated Fluid and semi-fluid compositions including benzoate esters
US4287214A (en) * 1979-09-24 1981-09-01 Scott Eugene J Van Dithranol compositions stabilized with alpha hydroxyacids
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
FR2492372A1 (fr) * 1980-10-21 1982-04-23 Cird Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
FR2492373A1 (fr) * 1980-10-21 1982-04-23 Cird Adducts de dihydroxy-1,8 anthrone-9 et leur utilisation en medecine humaine ou veterinaire et en cosmetique
CA1179271A (fr) * 1981-10-23 1984-12-11 Jean-Francois Grollier Composition epaissie anhydre, stable a l'oxydation, a base d'anthraline ou de l'un de ses derives dans un support constitue d'un alkyl ester d'acide gras et d'un agent epaississant, et son utilisation dans le traitement des maladies de la peau

Also Published As

Publication number Publication date
FR2520233A1 (fr) 1983-07-29
GB8302283D0 (en) 1983-03-02
IT8319306A1 (it) 1984-07-27
IT1193627B (it) 1988-07-21
DE3302739A1 (de) 1983-08-04
BE895718A (fr) 1983-07-27
CA1187800A (fr) 1985-05-28
GB2113547A (en) 1983-08-10
GB2113547B (en) 1985-02-20
DE3302739C2 (enExample) 1991-01-24
JPH0340009B2 (enExample) 1991-06-17
US4504494A (en) 1985-03-12
CH653554A5 (fr) 1986-01-15
IT8319306A0 (it) 1983-01-27
JPS58134025A (ja) 1983-08-10
AU1091483A (en) 1983-08-04

Similar Documents

Publication Publication Date Title
FR2523637B1 (enExample)
DE3376339T2 (enExample)
CH669858C2 (enExample)
FR2519544B1 (enExample)
DE3377744D1 (enExample)
GR78928B (enExample)
DE3241530C2 (enExample)
FR2524559B1 (enExample)
FR2524650B1 (enExample)
FR2522759B1 (enExample)
DE3347860A1 (enExample)
GR79365B (enExample)
FR2520233B1 (enExample)
FR2519470B1 (enExample)
CH670543GA3 (enExample)
FR2519564B1 (enExample)
CS8203229A (enExample)
DE3348035A1 (enExample)
FR2524649B1 (enExample)
CH675516GA3 (enExample)
JPS59500008U (enExample)
FR2521775B3 (enExample)
DE3377439T2 (enExample)
FR2522889B1 (enExample)
FR2519580B1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse